Targeting mutant estrogen receptors.
Publication
, Journal Article
Wardell, SE; Norris, JD; McDonnell, DP
Published in: Elife
January 16, 2019
A drug used in hormone replacement therapy can target estrogen receptors that have become resistant to breast cancer treatments.
Duke Scholars
Published In
Elife
DOI
EISSN
2050-084X
Publication Date
January 16, 2019
Volume
8
Location
England
Related Subject Headings
- Selective Estrogen Receptor Modulators
- Receptors, Estrogen
- Mutation
- Mutant Proteins
- Humans
- Female
- Breast Neoplasms
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 31 Biological sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wardell, S. E., Norris, J. D., & McDonnell, D. P. (2019). Targeting mutant estrogen receptors. Elife, 8. https://doi.org/10.7554/eLife.44181
Wardell, Suzanne E., John D. Norris, and Donald P. McDonnell. “Targeting mutant estrogen receptors.” Elife 8 (January 16, 2019). https://doi.org/10.7554/eLife.44181.
Wardell SE, Norris JD, McDonnell DP. Targeting mutant estrogen receptors. Elife. 2019 Jan 16;8.
Wardell, Suzanne E., et al. “Targeting mutant estrogen receptors.” Elife, vol. 8, Jan. 2019. Pubmed, doi:10.7554/eLife.44181.
Wardell SE, Norris JD, McDonnell DP. Targeting mutant estrogen receptors. Elife. 2019 Jan 16;8.
Published In
Elife
DOI
EISSN
2050-084X
Publication Date
January 16, 2019
Volume
8
Location
England
Related Subject Headings
- Selective Estrogen Receptor Modulators
- Receptors, Estrogen
- Mutation
- Mutant Proteins
- Humans
- Female
- Breast Neoplasms
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 31 Biological sciences